Nasdaq: GPCR
Structure Therapeutics insiders
The officers, directors and 10% owners of Structure Therapeutics Inc. who hold the most stock, valued at the live GPCR price.
$17.12
GPCR today −$240K (−1.38%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 0
- Their GPCR stock
- $0
- Market value
- $1.27B
- Held by ranked insiders
- <0.1%
Insiders by value of GPCR holdings
SEC ownership pageNo insider of Structure Therapeutics currently holds enough stock to make the list.
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Structure Therapeutics; see each profile for the filing.